Bolivia vs Malaysia: Access to anti-retroviral drugs, male (%)
Bolivia
59.0%
in 2024
Malaysia
59.0%
in 2024
Bolivia rank
105th
Malaysia rank
105th
Access to anti-retroviral drugs, male (%) over time
- Bolivia
- Malaysia
How they compare
Bolivia currently reports 59.0% against 59.0% in Malaysia, a difference of 0.0%.
Across all 25 years both countries report, Malaysia has been ahead every year.
Bolivia ranks 105th and Malaysia ranks 105th of 141 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 7.2% | 5.7% | Malaysia |
| 2010s | 19.0% | 29.7% | 10.7% | Malaysia |
| 2020s | 51.4% | 55.6% | 4.2% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bolivia or Malaysia?
- Bolivia, at 59.0% against 59.0% in Malaysia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bolivia and Malaysia?
- 0.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia and Malaysia rank globally for access to anti-retroviral drugs, male?
- Bolivia ranks 105th and Malaysia ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.